Drug Free Solution Stock Fundamentals
| DSOL Stock | USD 0.0002 0.00 0.00% |
Drug Free Solution fundamentals help investors to digest information that contributes to Drug Free's financial success or failures. It also enables traders to predict the movement of Drug Pink Sheet. The fundamental analysis module provides a way to measure Drug Free's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Drug Free pink sheet.
Drug |
Drug Free Solution Company Shares Outstanding Analysis
Drug Free's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Drug Free Shares Outstanding | 35.94 M |
Most of Drug Free's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Drug Free Solution is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, Drug Free Solution has 35.94 M of shares currently outstending. This is 80.09% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The shares outstanding for all United States stocks is 93.71% higher than that of the company.
Drug Free Solution Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Drug Free's current stock value. Our valuation model uses many indicators to compare Drug Free value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Drug Free competition to find correlations between indicators driving Drug Free's intrinsic value. More Info.Drug Free Solution is one of the top stocks in return on asset category among its peers. It also is one of the top stocks in operating margin category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Drug Free's earnings, one of the primary drivers of an investment's value.Drug Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Drug Free's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Drug Free could also be used in its relative valuation, which is a method of valuing Drug Free by comparing valuation metrics of similar companies.Drug Free is currently under evaluation in shares outstanding category among its peers.
Drug Fundamentals
| Return On Asset | -12.7 | |||
| Operating Margin | (413.00) % | |||
| Current Valuation | 496.08 K | |||
| Shares Outstanding | 35.94 M | |||
| Price To Earning | (1.56) X | |||
| Price To Sales | 239.51 X | |||
| Gross Profit | (171.22 K) | |||
| EBITDA | (862.83 K) | |||
| Net Income | (755.87 K) | |||
| Cash And Equivalents | 7.12 K | |||
| Current Ratio | 0.02 X | |||
| Book Value Per Share | (0) X | |||
| Cash Flow From Operations | (692.31 K) | |||
| Earnings Per Share | (0.01) X | |||
| Beta | -4.9 | |||
| Market Capitalization | 503.2 K | |||
| Total Asset | 11.79 K | |||
| Retained Earnings | (1.68 M) | |||
| Working Capital | (384 K) | |||
| Current Asset | 7 K | |||
| Current Liabilities | 391 K | |||
| Net Asset | 11.79 K |
About Drug Free Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Drug Free Solution's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Drug Free using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Drug Free Solution based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Drug Free Solution, Inc., a lifestyle company, delivers proprietary emotional wellness technology, known as Living Breath Process. The company was formerly known as Living Breath Project, Inc. and changed its name to Drug Free Solution, Inc. in January 2014. DRUG FREE is traded on PNK Exchange in the United States.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Drug Pink Sheet
Drug Free financial ratios help investors to determine whether Drug Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Drug with respect to the benefits of owning Drug Free security.